By differential display we demonstrated that antibody-mediated
ligation of the GPI-linked
protein product of E48, a newly discovered human Ly-6 gene, up-regulates the expression of the
FX enzyme in 3 lines of head and neck
squamous carcinoma cells. FX is responsible for the last step in the synthesis of
GDP-L-
fucose. The up-regulation of FX was E48
ligand-specific. 22AWT head and neck
squamous carcinoma cells expressing high levels of E48 expressed significantly higher levels of FX than the E48 antisense transfected 22AWT cells (8-3 cells). The former cells also expressed higher levels of two major fucosylated
glycans (the
selectin ligand,
Sialyl Lewis a, and VIM-2) than the E48 antisense transfectants. Conversely, transfection of cells from the 14CWT line expressing very low levels of E48 with E48
cDNA caused an up-regulated expression of FX and of the two fucosylated
glycans in the 14C-CMV16 transfectants. Moreover, the expression levels of
Sialyl Lewis a was significantly up-regulated on
HNSCC upon
ligation of E48 by anti-E48
antibodies. The functional significance of the E48-mediated up-regulation of
Sialyl Lewis a was demonstrated in rolling experiments on
E-selectin bearing surfaces under physiological conditions of shear flow and on
tumor necrosis factor alpha-activated human umbilical venous endothelial cells. Only high E48/FX/
Sialyl Lewis a expressing 14C-CMV16 cells could roll on purified
E-selectin or establish
E-selectin dependent rolling on the activated human umbilical venous endothelial cells. Low E48/FX/
Sialyl Lewis a expressing 14CWT cells did not roll. These results show that E48 controls the expression of the
FX enzyme and of certain fucosylated
E-selectin ligands by
HNSCC. E48 may thus function as a key regulator of the adhesiveness of these
tumor cells to inflamed vessel walls expressing
E-selectin.